| Product Code: ETC9409329 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Nucleic Acid-Based Drugs Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Nucleic Acid-Based Drugs Market - Industry Life Cycle |
3.4 South Korea Nucleic Acid-Based Drugs Market - Porter's Five Forces |
3.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Category, 2021 & 2031F |
3.6 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Target, 2021 & 2031F |
3.8 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Mechanism, 2021 & 2031F |
3.9 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Nucleic Acid-Based Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in South Korea |
4.2.2 Growing RD investments in nucleic acid-based drugs |
4.2.3 Favorable government regulations supporting the development and adoption of nucleic acid-based drugs |
4.3 Market Restraints |
4.3.1 High costs associated with nucleic acid-based drug development and manufacturing |
4.3.2 Limited awareness and understanding of nucleic acid-based drugs among healthcare professionals and patients |
5 South Korea Nucleic Acid-Based Drugs Market Trends |
6 South Korea Nucleic Acid-Based Drugs Market, By Types |
6.1 South Korea Nucleic Acid-Based Drugs Market, By Category |
6.1.1 Overview and Analysis |
6.1.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Category, 2021- 2031F |
6.1.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Antisense, 2021- 2031F |
6.1.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By SiRNA, 2021- 2031F |
6.1.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By MiRNA, 2021- 2031F |
6.1.6 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Aptamer, 2021- 2031F |
6.1.7 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Decoy, 2021- 2031F |
6.1.8 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By CpG-oilgo, 2021- 2031F |
6.2 South Korea Nucleic Acid-Based Drugs Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Single Stranded DNA/RNA, 2021- 2031F |
6.2.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Double Stranded DNA, 2021- 2031F |
6.2.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Single-Stranded DNA, 2021- 2031F |
6.2.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Nucleic Acid-Based Drugs Market, By Target |
6.3.1 Overview and Analysis |
6.3.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Transcriptor Factor, 2021- 2031F |
6.3.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By TLR9-Receptor, 2021- 2031F |
6.3.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Protein, 2021- 2031F |
6.4 South Korea Nucleic Acid-Based Drugs Market, By Mechanism |
6.4.1 Overview and Analysis |
6.4.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Inhibits the Physiological Effect, 2021- 2031F |
6.4.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Adjuvant, 2021- 2031F |
6.4.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Inhibits Transcription, 2021- 2031F |
6.4.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 South Korea Nucleic Acid-Based Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 South Korea Nucleic Acid-Based Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 South Korea Nucleic Acid-Based Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Nucleic Acid-Based Drugs Market Import-Export Trade Statistics |
7.1 South Korea Nucleic Acid-Based Drugs Market Export to Major Countries |
7.2 South Korea Nucleic Acid-Based Drugs Market Imports from Major Countries |
8 South Korea Nucleic Acid-Based Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for nucleic acid-based drugs in South Korea |
8.2 Percentage increase in government funding for nucleic acid-based drug research |
8.3 Adoption rate of nucleic acid-based drugs in South Korean healthcare facilities |
9 South Korea Nucleic Acid-Based Drugs Market - Opportunity Assessment |
9.1 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By Category, 2021 & 2031F |
9.2 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By Target, 2021 & 2031F |
9.4 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By Mechanism, 2021 & 2031F |
9.5 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 South Korea Nucleic Acid-Based Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Nucleic Acid-Based Drugs Market - Competitive Landscape |
10.1 South Korea Nucleic Acid-Based Drugs Market Revenue Share, By Companies, 2024 |
10.2 South Korea Nucleic Acid-Based Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here